Brought to you by 
Evotec, Roche develop cancer therapeutic
09 Mar 2020
Executive Summary
Building on its 2001 agreement, Evotec (drug discovery and development technologies) and Roche have expanded the terms to include the identification and development of a clinical drug candidate for a Roche cancer target.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Evotec, Roche develop cancer therapeutic
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice